(Q45830674)

16 December 2017

title

Changes of hepatitis B virus (HBV) markers during prolonged recombinant interferon alpha-2A treatment of chronic HBV infection (English)

1 reference

16 December 2017

1 reference

Mora I

1

1 reference

16 December 2017

Porres JC

2

1 reference

16 December 2017

Bartolomé J

3

1 reference

16 December 2017

Quiroga JA

4

1 reference

16 December 2017

Gutiez J

5

1 reference

16 December 2017

Hernández Guio C

6

1 reference

16 December 2017

Bas C

7

1 reference

16 December 2017

Carreño V

8

1 reference

16 December 2017

publication date

1 February 1987

1 reference

16 December 2017

published in

Journal of Hepatology

1 reference

16 December 2017

volume

4

1 reference

16 December 2017

issue

1

1 reference

16 December 2017

page(s)

29-36

1 reference

16 December 2017

Natural history of the HBsAg carrier

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Analysis of liver disease, nuclear HBcAg, viral replication, and hepatitis B virus DNA in liver and serum of HBeAg Vs. anti-HBe positive carriers of hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Seroconversion from Hepatitis B e Antigen to Antibody in Chronic Type B Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Randomised controlled trial of adenine arabinoside 5'-monophosphate (ARA-AMP) in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Acyclovir inhibits hepatitis B virus replication in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Effect of human leukocyte interferon on hepatitis B virus infection in patients with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Antiviral Treatment of Chronic Hepatitis B Virus Infection: Infectious Virus Cannot Be Detected in Patient Serum after Permanent Responses to Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Double-blind study of leucocyte interferon administration in chronic HBsAg-positive hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Treatment of chronic hepatitis due to hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Acute Dane particle suppression with recombinant leukocyte A interferon in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Recombinant leukocyte a interferon treatment in patients with chronic hepatitis B virus infection. Pharmacokinetics, tolerance, and biologic effects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Pilot study of recombinant human alpha-interferon for chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Virus receptors for polymerized human albumin: A prognostic marker in HBeAg-positive chronic hepatitis type B?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Enzyme-linked immunosorbent assay for detection of receptors for polymerized human serum albumin on hepatitis B surface antigen particles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Hemagglutination and immunofluorescence studies on polymerized human serum albumin binding activity in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Persistence of circulating HBsAg/IgM complexes in acute viral hepatitis, type B: an early marker of chronic evolution

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Complexes between HBsAg and IgM in serum of patients with acute hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Inactivation of DNA-polymerase associated with hepatitis B virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

The detection of HBV-DNA in serum by molecular hybridisation: a more sensitive method for the detection of complete HBV particles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Binding activity of HBsAg particles from chronic HBsAg carriers to polystyrene beads coated with polymerized human serum albumin: diagnostic relevance of the assay

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Correlations between anti-albumin antibodies and HBsAG in hepatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Complexes of hepatitis B surface antigen and immunoglobulin M in the sera of patients with hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Comparative study of DHBV DNA levels and endogenous DNA polymerase activity in naturally infected ducklings in France

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Assay of HBV DNA in the plasma of HBV-carrier chimpanzees superinfected with non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Detection of an IgM antiidiotype directed against anti-HBs in hepatitis B patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Polyalbumin receptors on hepatitis B virus and on 22 nm hepatitis B surface antigen (H BsAg)2 particles

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Secretion of polyalbumin receptors in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

Low doses of interferon alpha result in more effective clinical natural killer cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2887%2980006-5

7 January 2021

10.1016/S0168-8278(87)80006-5

Identifiers

DOI

1 reference

16 December 2017

1 reference

16 December 2017